Abstract: Methods for delivering at least one compound selected from nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, in combination with at least one of thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), and pyridoxine (vitamin B6), to an infant human subject in need of said compound or compounds are provided.
Type:
Grant
Filed:
April 14, 2017
Date of Patent:
December 8, 2020
Assignee:
ChromaDex, Inc.
Inventors:
Ryan Dellinger, Troy Rhonemus, Mark Morris, Dietrich Conze, Amy Boileau
Abstract: Derivatives of nicotinic acid riboside (NAR), nicotinamide riboside (NR), and reduced NAR and NR, including 1-(2?,3?,5?-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid (4a), and compositions containing the same and/or reduced derivative forms of nicotinamide riboside including 1-(2?,3?,5?-triacetyl-beta-D-ribofuranosyl)-1,4-nicotinamide (2), are provided for use in the care of treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing one or more NR, NAR, NRH, or NARH derivatives, or prodrugs or salts thereof. In further embodiments, the invention relates to methods of using one or more NR, NAR, NRH, or NARH derivatives, or prodrugs, solvates, or salts thereof, to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival and overall cell and tissue health.
Type:
Grant
Filed:
March 16, 2016
Date of Patent:
May 7, 2019
Assignees:
ChromaDex, Inc., The Queen's University of Belfast
Inventors:
Ryan Dellinger, Marie Eugenie Migaud, Philip Redpath, Troy Rhonemus, Richard Cunningham
Abstract: Methods for delivering at least one compound selected from nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, in combination with at least one of thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), and pyridoxine (vitamin B6), to an infant human subject in need of said compound or compounds are provided.
Type:
Application
Filed:
April 14, 2017
Publication date:
October 19, 2017
Applicant:
ChromaDex, Inc.
Inventors:
Ryan Dellinger, Troy Rhonemus, Mark Morris, Dietrich Conze, Amy Boileau
Abstract: A synthetic process is provided for the preparation of phosphorylated analogs of nicotinamide riboside (“NR”) having the formula (I), or salts thereof, and reduced or modified derivatives thereof, having the formula (II), wherein X?, Y1, Y2, Z1, Z2, n, R1, R2, R3, R4, R5, R6, and R7 are as defined herein. The present disclosure also relates to the preparation of phosphorylated analogs of nicotinic acid riboside (“NAR”) having the formula (I), or salts thereof, and reduced or modified derivatives thereof, having the formula (II). Generally solvent-free conditions are employed using appropriate mechano-chemical techniques as described.
Type:
Application
Filed:
June 3, 2016
Publication date:
December 8, 2016
Applicants:
ChromaDex, Inc., The Queen's University of Belfast
Inventors:
Marie Eugenie Migaud, Philip Redpath, Kerri Crossey, Richard Cunningham, Troy Rhonemus, Sylesh Venkataraman
Abstract: The present invention relates to a process of providing an extract containing at least one simmondsin compound. The extract is provided from jojoba plant, and used as a dietary supplement for use in a weight control regiment in humans. The present invention also provides a method of treating an overweight human in need of such treatment, and comprises administering a therapeutically effective amount of such an extract.
Type:
Grant
Filed:
March 26, 2002
Date of Patent:
February 8, 2005
Assignees:
Avoca, Inc., ChromaDex, Inc.
Inventors:
Richard King Teague, Samuel Leonard Tynch, Frank Louis Jaksch, Jr., Richard Theodore Maier, Jr.